(Q73093118)

English

A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group

scientific article published on 01 August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

author name string

J B Vermorken

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Kobierska

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Chevallier

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Zanaboni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Pawinski

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Bolis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1035-1040

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of doxorubicin on survival in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Second trial drugs in ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Adriamycin in ovarian cancer patients resistant to cyclophosphamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of recurrent ovarian cancer: increasing options--"recurrent" results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments]

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin for pretreated advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 study with epirubicin as second-line treatment of patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

The taxoids. Comparative clinical pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008332517333

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008332517333

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038042%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73093118&oldid=1743569748"